在喘中维护和缓解Digihaler系统的有效性:24周随机研究 (CONNECT2)
Giselle S Mosnaim1, Flavia C L Hoyte2, Guilherme Safioti3
1Division of Pulmonary, Allergy and Critical Care, Department of Medicine, NorthShore University Health System, Evanston, Ill.
与标准护理相比,Digihaler系统 (DS) 改善了患者的喘控制. 这种数字健康工具可以增强吸入器技术和吸入力,从而改善喘管理.
科学领域:
- 数字健康数字健康
- 喘管理的管理
- 呼吸系统药物 呼吸系统药物
背景情况:
- 数字健康工具可以通过解决吸入器技术,坚持和药物过量使用来改善喘控制.
- 数字治疗系统 (DS) 包括吸入器,应用程序和仪表板,用于监测和临床决策.
研究的目的:
- 与标准护理 (SoC) 相比,评估Digihaler系统 (DS) 在改善喘控制方面的有效性.
主要方法:
- 一项为期24周的,开放的,随机的研究,将DS与SoC比较于13岁以上的非控制性喘参与者 (ACT得分<19).
- 主要终点:获得良好控制喘的患者比例 (ACT得分≥20或增加≥3个单位).
主要成果:
- DS显示了88.7%的改善喘控制的概率与SoC相比,改善的概率高出35%.
- DS组的临床医生互动增加,维持治疗的坚持改善,替补剂使用减少38.2%.
- 应用程序和仪表板的可用性被参与者评为"好".
结论:
- 迪吉哈勒系统 (DS) 有效地改善了非控制性喘患者的喘控制和坚持.
- 像DS这样的数字健康解决方案提供了一种有希望的方法来改善喘管理和患者的治疗结果.
更多相关视频
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
04:59Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
Published on: August 18, 2023
相关概念视频
Inhaled Medications
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
COPD: Management Using Bronchodilators and Corticosteroids
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
